CIK 0001314052 · Large accelerated filer<br>Smaller reporting company
ANAVEX LIFE SCIENCES CORP.
Sign in to watch- Ticker
- AVXL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Entity type
- operating
- EIN
- 980608404
- Phone
- 844-689-3939
- Business address
- 630 5TH AVENUE, 20TH FLOOR, NEW YORK, NY, 10111
- Former names
- Thrifty Printing Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-28 | MISSLING CHRISTOPHER U President and CEO | Sale | −73,380 | $5.11 | $375K | 1,250,210 |
| 2024-03-28 | MISSLING CHRISTOPHER U President and CEO | Option exercise · Stock Option (Right to Buy) | −73,380 | 0 | ||
| 2024-02-20 | Donhauser Peter D.O. Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2024-02-20 | Velden Claus Vander Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2024-02-20 | Thomas Steffen Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2024-02-20 | Ma Jiong Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2024-02-20 | Skarpelos Athanasios Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2024-01-02 | MISSLING CHRISTOPHER U President and CEO | Grant or award · Stock Option (Right to Buy) | −125,000 | 125,000 | ||
| 2024-01-02 | Boenisch Sandra PFO & Treasurer | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2023-06-29 | MISSLING CHRISTOPHER U President and CEO | Option exercise | +232,000 | $1.60 | $371K | 1,250,210 |
| 2023-06-29 | MISSLING CHRISTOPHER U President and CEO | Option exercise · Stock Option (Right to Buy) | −232,000 | 0 | ||
| 2023-06-28 | MISSLING CHRISTOPHER U President and CEO | Option exercise | +268,000 | $1.60 | $429K | 1,286,210 |
| 2023-06-28 | MISSLING CHRISTOPHER U President and CEO | Sale | −268,000 | $7.98 | $2.1M | 1,018,210 |
| 2023-06-28 | MISSLING CHRISTOPHER U President and CEO | Option exercise · Stock Option (Right to Buy) | −268,000 | 232,000 | ||
| 2023-03-31 | Ma Jiong Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-03-31 | Thomas Steffen Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-03-31 | Velden Claus Vander Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-03-31 | Donhauser Peter D.O. Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-03-31 | Skarpelos Athanasios Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2022-06-27 | Velden Claus Vander Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 |
Page 3 of 12 · 232 trades